President Trump’s splashiest idea for lowering the cost of prescription drug prices was to force pharmaceutical companies to include the prices of their products in TV and other advertisements.
By Philip Moeller
It’s often possible to find individual drugs that cost less than what you’d pay in a Part D plan.
Rushing to judgment is misguided. There are no quick fixes here, and while the Trump proposals are viewed as fatally flawed by many experts, they also include some worthy ideas.
President Trump laid out his long-awaited plan for tackling drug prices on Friday. Health and Human Services Secretary Alex Azar joins Judy Woodruff to fill in the details about the plan, including how it will affect prices under Medicare, why…
President Trump revealed his blueprint to lower prescription drug prices as he railed against the pharmaceutical industry for making them unaffordable. Under his plan, "American Patients First," Trump proposes making it easier for generic drugs to enter the market and…
By Matthew Perrone, Associated Press
Trump called his plan the "most sweeping action in history to lower the price of prescription drugs for the American people." But it does not include his campaign pledge to use the massive buying power of the government's Medicare program…
By Erin Mershon, STAT
When the Trump administration unveiled a new Medicare proposal this week to cut payments to hospitals as part of a drug reimbursement program, Health and Human Services Secretary Tom Price called the plan a “significant step toward fulfilling President Trump’s…
By Ed Silverman, STAT
The cost of two widely used radiology medicines for lung and kidney scans has jumped between 500 percent and 1,800 percent over the last four years.
By Bruce Horovitz and Julie Appleby, Kaiser Health News
Spending on direct-to-consumer drug commercials grew 62 percent since 2012, even as ad spending for most other product types was flat.
By Sarah Jane Tribble, Kaiser Health News
For years, congressional Democrats have tried to pass legislation to allow Medicare to negotiate prescription drug prices for millions of beneficiaries. Now, they believe they have a not-so-secret weapon: President Donald Trump.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.